Why the study?
Does baseline QTc prolongation increase the risk of cardiac-related events in patients undergoing electroconvulsive therapy?
Does baseline QTc prolongation increase the risk of cardiac-related events in patients undergoing electroconvulsive therapy?
Baseline QTc prolongation is associated with an increased risk of cardiac-related events during ECT, warranting careful consideration but not absolute contraindication.
BACKGROUND: Prolonged QTc intervals have been associated with increased cardiac morbidity and mortality. We investigated whether pretreatment prolongation of the QTc interval was associated with increased cardiac-related events (CREs) in electroconvulsive therapy (ECT) treatment of psychiatric disorders. METHODS: The charts of 1437 ECT patients were reviewed for the presence of baseline QTc prolongation. Broadly defined CREs during the course of treatment were abstracted from patient charts. RESULTS: Presence of baseline QTc prolongation was not independent of increased risk of CREs during ECT. IMPLICATIONS: Careful consideration should be given to patients who have QTc prolongation on an electrocardiogram and are undergoing ECT treatment, but this should not definitively exclude patients from receiving ECT treatment.
No takes yet. Share an insight, caveat, or question.
Pullen et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: